Skip to main content
Adam Asch, MD, Oncology, Oklahoma City, OK

AdamAschMD

Oncology Oklahoma City, OK

Professor of Medicine, University of Oklahoma Health Sciences Center, Nancy Johnston Records Chair in Oncology, Senior Deputy Director Stephenson Cancer Center, Division Chief Hematology-Oncology

Dr. Asch is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Asch's full profile

Already have an account?

  • Office

    1122 NE 13th St
    Oklahoma City, OK 73117
    Phone+1 405-271-8299
    Fax+1 405-271-9180

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 1982 - 1984
  • Zucker School of Medicine at Hofstra/Northwell
    Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1979 - 1982
  • Sidney Kimmel Medical College at Thomas Jefferson University
    Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1979
  • Swarthmore College
    Swarthmore CollegeAB

Certifications & Licensure

  • OK State Medical License
    OK State Medical License 2014 - 2025
  • NC State Medical License
    NC State Medical License 2006 - 2015
  • NY State Medical License
    NY State Medical License 1982 - 2008
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Research Award JDRF, 2001
  • Research Career Development Award NIH, 1990
  • Stratton Foundation Award 1989
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • A phase II trial of bendamustine in combination with rituximab in older patients with previously untreated diffuse large B-cell lymphoma  
    Park SI, Grover NS, Olajide O, Asch AS, Wall JG, Richards KL, Sobol AL, Deal AM, Ivanova A, Foster MC, Muss HB, Shea TC, Br J Haematol, 1/22/2016
  • Emerging links among Chromosome Instability (CIN), cancer, and aging  
    Rao CV, Asch AS, Yamada HY, Mol Carcinog, 1/17/2016
  • Caenorhabditis elegans: a model system for anti-cancer drug discovery and therapeutic target identification  
    Kobet RA, PanX, Zhang B, Pak SC, Asch AS, LeeMH, Biomol. Ther., 1/1/2014
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • A Phase I/II Study of AZD2811 Nanoparticles (NP) As Monotherapy or in Combination in Treatment-Na¥ve or Relapsed/Refractory AML/MDS Patients Not Eligible for Intensive...
    Adam S. Asch, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • The First-in-Class Anti-CD47 Antibody Magrolimab (5F9) in Combination with Azacitidine Is Effective in MDS and AML Patients: Ongoing Phase 1b Results
    Adam S. Asch, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Activation of the Proton-Sensing GPR4 Receptor Stimulates Vascular Endothelial Cell Inflammatory Responses Revealed by Transcriptome Analysis
    Dong L, Li, Leffler N, Asch AS, Yang Y, 102nd Annual Meeting of the American Association for Cancer Research, 1/2/2011
  • Join now to see all

Lectures

  • Role of Somatic Mutations and Clonal Thrombopoiesis in Immune Thrombocytopenia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Thrombocytopenia Is a Biomarker for Response in Patients Treated with Anti PD-1/Pdl-1 Therapy 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Role of translational control in lineage commitment and plasticity 
    1/1/2005
  • Join now to see all

Press Mentions

  • Honorees Named for Health Care Heroes Event
    Honorees Named for Health Care Heroes EventDecember 10th, 2019
  • Pulling Back the Curtain: Roy Silverstein, MD
    Pulling Back the Curtain: Roy Silverstein, MDDecember 1st, 2019
  • Oklahoma Man Finds Hope from Revolutionary New Cancer Treatment
    Oklahoma Man Finds Hope from Revolutionary New Cancer TreatmentNovember 28th, 2019
  • Join now to see all